People and society

Orexo’s efforts to create added value for patients and other stakeholders and to ensure access to quality pharmaceutical products has a positive impact on several sustainability aspects

Sustainable Development Goal #3 – Good Health and Well-being

The 2030 Agenda for Sustainable Development and the 17 Sustainable Development Goals were adopted by the United Nations in 2015. The goals and their specific targets together aim at ending poverty, protecting the planet and ensuring prosperity for all.

Sustainable Development Goal number 3 and its target 3.5 is of especial importance to Orexo. The goal seeks to ensure health and well-being for all, at every stage of life and addresses all major health priorities, including universal health coverage and access for all to safe, effective, quality and affordable medicines. The target is intented to strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol.

Through the Business Compliance and Ethics Code Orexo supports the International Bill of Human Rights and the ILO Declaration on Fundamental Principles and Rights at Work. The company’s highest risks of violation of these rights are, however, in the Supply Chain, beyond the direct control of the company. Hence, in the Human Rights issue area the company works with enhancing external performance and the commitment is enforced through the Supplier Code of Conduct and the Supplier Management Principles.


Within the overall sustainability work, we focus our environmental efforts on product development, the supply of goods and the handling of chemicals. We are committed to continuing reduce the environmental impacts of our business and our products by increasing energy efficiency, reducing consumption of materials, improving waste management and by keeping emissions of pharmaceutical substances at low levels. In order to reduce business travel, the company encourages business meetings to be held by telephone or on the web.

In order to ensure that the company follows current environmental laws, regulations, directives and requirements and has satisfactory internal control, operations are conducted in line with our environmental management system. The system is aligned with ISO 14001, but there are at present no plans to certify the system accordingly. Our environmental group, consisting of representatives from different parts of the company, is responsible for monitoring and continually improving our environmental work and for employees receiving appropriate environmental training and information.


Orexo has a workforce of approximately one hundred people evenly distributed between Sweden and the United States. As a company with its roots in Sweden and a subsidiary in another developed country, fundamental labor rights standards such as the abolition of child labor, maintaining freedom of association and elimination of forced and compulsory labor are generally both ethically and legislatively well developed. Orexo, however, recognizes the local and global challenges of inequality in respect of employment and occupationally inflicted health issues.

Through our Business Compliance and Ethics Code we condemn any form of harassment or discrimination including such characteristics protected by applicable laws and regulations. To enforce the policy the Swedish organization maintains an equal opportunities plan which is updated with on a regular basis.


A recognized risk for businesses within the healthcare sector is ethics and compliance violations in interactions with Healthcare Professionals (HCP), Healthcare Organizations and Government Officials. The legislation in this area is comprehensive, not the least in the US with the Physician Payments Sunshine Act as an example where transparent disclosure of expenses in relations with HCPs is required. In order to complement the legislation and to communicate internally and externally what values should permeate our business conduct, we have formed global and local policy programs.